1. Home
  2. ESLT vs ONC Comparison

ESLT vs ONC Comparison

Compare ESLT & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elbit Systems Ltd.

ESLT

Elbit Systems Ltd.

HOLD

Current Price

$774.64

Market Cap

35.2B

Sector

Industrials

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$318.72

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESLT
ONC
Founded
1966
2010
Country
Israel
Switzerland
Employees
N/A
12000
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2B
31.4B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
ESLT
ONC
Price
$774.64
$318.72
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$667.00
$385.10
AVG Volume (30 Days)
76.4K
286.8K
Earning Date
05-26-2026
05-06-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.29
$723.76
Revenue Next Year
$8.49
$15.04
P/E Ratio
$71.88
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$432.85
$253.95
52 Week High
$1,016.06
$385.22

Technical Indicators

Market Signals
Indicator
ESLT
ONC
Relative Strength Index (RSI) 51.09 65.81
Support Level $745.37 $305.56
Resistance Level $821.25 $328.39
Average True Range (ATR) 18.61 7.98
MACD 2.49 1.93
Stochastic Oscillator 53.17 84.86

Price Performance

Historical Comparison
ESLT
ONC

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security and commercial flight capabilities. Its systems and solutions may be installed on new platforms or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company operates in five segments: Aerospace; C4I and Cyber; ISTAR and EW; Land; and ESA. It derives maximum revenue from Land Segment. Geographically, it operates in Israel; North America; Europe; Asia-Pacific; Latin America; and Others.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: